Chemours
431 hedge funds and large institutions have $3.44B invested in Chemours in 2021 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 120 increasing their positions, 114 reducing their positions, and 65 closing their positions.
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
12% more capital invested
Capital invested by funds: $3.08B → $3.44B (+$365M)
8% more first-time investments, than exits
New positions opened: 70 | Existing positions closed: 65
5% more repeat investments, than reductions
Existing positions increased: 120 | Existing positions reduced: 114
0% more funds holding
Funds holding: 429 → 431 (+2)
0.7% less ownership
Funds ownership: 75.68% → 74.98% (-0.7%)
26% less call options, than puts
Call options by funds: $36.5M | Put options by funds: $49.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VNIM
Vaughan Nelson Investment Management
Houston,
Texas
|
+$54.1M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$15.9M |
| 3 |
BlackRock
New York
|
+$14.7M |
| 4 |
Wells Fargo
San Francisco,
California
|
+$14.2M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$13.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$109M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$27.1M |
| 3 |
Two Sigma Investments
New York
|
-$16.1M |
| 4 |
SC
Sessa Capital
New York
|
-$15.8M |
| 5 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$12.8M |
CC Hedge Fund Activity: Q1 2021 in Review
431 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Chemours (CC) for Q1 2021, worth a combined $3.44B — up 12% from $3.08B a quarter earlier.
Buyers outnumbered sellers: 70 funds opened new CC positions and 65 closed out — a net gain of 5 holders — while 120 added to existing stakes and 114 trimmed.
The largest buyer was Vaughan Nelson Investment Management, opening a new position worth an estimated $54.1M. The largest seller was Fidelity Investments, cutting an estimated $109M.
- 431 institutional investors held Chemours (CC) as of Q1 2021, up from 429 in Q4 2020.
- Funds reported $3.44B of Chemours stock for Q1 2021, up 12% quarter-over-quarter.
- 70 funds opened new Chemours positions in Q1 2021 and 65 closed out, a net change of +5 holders.
- The largest Chemours buyer in Q1 2021 was Vaughan Nelson Investment Management, an estimated $54.1M added.
- The largest Chemours seller in Q1 2021 was Fidelity Investments, an estimated $109M sold.
Based on aggregated 13F filings for Q1 2021.